Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25306776 | 0.91 | TAAR1 (0.59) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL8905812 | 0.89 | TAAR1 (0.48) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL2093230 | 0.82 | TAAR1 (0.50) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL8904835 | 0.82 | TSHR (0.50) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL5911548 | 0.81 | TAAR1 (0.48) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL919641 | 0.81 | — | — | |
| SCHEMBL150607 | 0.80 | — | — | |
| SCHEMBL5911180 | 0.80 | TAAR1 (0.52) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL8905908 | 0.79 | SLC1A3 (0.42) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 | |
| SCHEMBL9508096 | 0.79 | TSHR (0.48) | TSHRALDH1A1SMN1; SMN2POLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5659065-A | CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS | NOVARTIS CORPORATION (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0678500-A1 | Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors | CIBA-GEIGY AG (CH) | 1995-10-25 | — | — | EP | disclosed |